As of Feb 16
| +0.0125 / +1.53%|
The 1 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +321.69% increase from the last price of 0.83.
The current consensus among 1 polled investment analysts is to Hold stock in Orexigen Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.